European Equities Traded in the US as American Depositary Tread Water in Friday Trading

MT Newswires Live12-07

European equities traded in the US as American depositary receipts were treading water late Friday morning, edging 0.055% higher to 1,351.69 on the S&P Europe Select ADR Index, which has gained 1.4% for the week.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and internet browser company Opera (OPRA), which rose 4.4% and 2.3% respectively. They were followed by 3D printer company Materialise (MTLS) and pharmaceutical company Novo Nordisk (NVO), which were up 1.9% and 1.7% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and petroleum refiner Equinor (EQNR), which fell 4% and 3.1% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and oil and gas company Eni (E), which were down 2.4% and 0.8% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Mereo BioPharma Group (MREO) and Bicycle Therapeutics (BCYC), which advanced 9.2% and 3% respectively. They were followed by software firm Endava (DAVA) and pharmaceutical company Silence Therapeutics (SLN), which increased by 4.1% and 2.5% respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which dropped 10% and 1.5% respectively. They were followed by oil and gas companies BP (BP) and Shell (SHEL), which lost 1.4% and 1.3% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment